Frequency of Human Papillomavirus Infection, Coinfection, and Association with Different Risk Factors in Colombia

Annals of Epidemiology

Volumn 21, Issue 3, 2011, Pages 204-213

  Camargo, Milena ^a,b   Soto De Leon, Sara C ^a,b   Sanchez, Ricardo ^a,c   Perez Prados, Antonio ^d   Patarroyo, Manuel E ^a,c   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Cervical Intraepithelial Neoplasia; Colombia; Epidemiology; Papillomavirus Infections; Risk Factors

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLOMBIA; CONTROLLED STUDY; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; COLOMBIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, VIRAL; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79551518506     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.11.003     Document Type: Article

References (43)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Molano M., Posso H., Mendez F., Murillo R., Van Den Brule A., Ronderos M., et al. Historia Natural de la infección por el virus de papiloma Humano en una cohorte de Bogotá, D.C. Colombia. Revista Colombiana de Cancerología 2005, 9:209-226.
3. Pardo C., Murillo R., Piñeros M., Castro M.A. New Cancer Cases at the Instituto Nacional de Cancerología, Colombia, 2002. Revista Colombiana de Cancerología 2003, 7:4-19.
4. Mendez F., Munoz N., Posso H., Molano M., Moreno V., van den Brule A.J., et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005, 192:1158-1165.
5. Sierra-Torres C.H., Acosta-Aragón M.P., Orejuela-Aristizabal L. Papilomavirus and factors associated with high-risk, cervical intra-epithelial neoplasia in Cauca, Colombia. Revista de Salud Pública 2006, 8:1-13.
6. Ochoa F.L., Montoya L.P. Mortalidad por Cáncer en Colombia en el año 2000: Cuando aumentar no es mejorar. Revista CES MEDICINA 2003, 17:7-22.
7. Olmos M., Acosta J., Preciado S., Arias S., Ballesteros M., Castillo J., et al. Recomendaciones para la tamización de neoplasias del cuello uterino en mujeres sin antecedentes de patología cervical (preinvasora o invasora) en Colombia 2007, Instituto Nacional de Cancerología (INS), Bogota D.C., Colombia, 64.
8. Cervantes J., Lema C., Hurtado L., Andrade R., Quiroga G., Garcia G., et al. Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon. Rev Inst Med Trop Sao Paulo 2003, 45:131-135.
9. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76:1057-1062.
10. Iftner T., Villa L.L. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003, 31:80-88.
11. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997, 35:1304-1310.
12. Karlsen F., Kalantari M., Jenkins A., Pettersen E., Kristensen G., Holm R., et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996, 34:2095-2100.
13. Lee Y.M., Leu S.Y., Chiang H., Fung C.P., Liu W.T. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001, 34:87-91.
14. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N., et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 2004, 42:3176-3184.
15. Parkin D.M., Almonte M., Bruni L., Clifford G., Curado M.P., Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008, 26(Suppl 11):L1-L15.
16. Orjuela K., Amador C., Patarroyo M.A. Synthetic genes: A tool for identifying human papillomavirus genotypes by hybridization and polymerase chain reaction-based assays. Diagn Microbiol Infect Dis 2007, 59:101-104.
17. Uribe C., Díaz L., Ortiz R., Meza E. Pap Smear Prevalence and that of Pre-Malignant and Malignant Cervical Lesions Amongst Women Living in the Carmen Initiative Demostration Area, Bucaramanga, Colombia. Revista Colombiana de Obstetricia y Ginecología 2006, 57:10-18.
18. Munoz N., Mendez F., Posso H., Molano M., van den Brule A.J., Ronderos M., et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004, 190:2077-2087.
19. Fuessel Haws A.L., He Q., Rady P.L., Zhang L., Grady J., Hughes T.K., et al. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004, 122:87-93.
20. WHO HPV and cervical cancer in the 2007 report. Vaccine 2007, 25(Suppl 3):C1-C230.
21. Ferrera A., Velema J.P., Figueroa M., Bulnes R., Toro L.A., Claros J.M., et al. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: A case-control study. Int J Cancer 1999, 82:799-803.
22. Almonte M., Albero G., Molano M., Carcamo C., Garcia P.J., Perez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008, 26:L16-L36.
23. Pannier-Stockman C., Segard C., Bennamar S., Gondry J., Boulanger J.C., Sevestre H., et al. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol 2008, 42:353-360.
24. Bello B.D., Spinillo A., Alberizzi P., Cesari S., Gardella B., D'Ambrosio G., et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009, 81:703-712.
25. Liu J., Rose B., Huang X., Liao G., Carter J., Wu X., et al. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 2004, 94:803-810.
26. Chaturvedi A.K., Dumestre J., Gaffga A.M., Mire K.M., Clark R.A., Braly P.S., et al. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 2005, 75:105-113.
27. Dobec M., Bannwart F., Kaeppeli F., Cassinotti P. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. J Clin Virol 2009, 45:23-27.
28. Antonishyn N.A., Horsman G.B., Kelln R.A., Saggar J., Severini A. The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy. Arch Pathol Lab Med 2008, 132:54-60.
29. Choo K.B., Pan C.C., Han S.H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987, 161:259-261.
30. Jeon S., Allen-Hoffmann B.L., Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995, 69:2989-2997.
31. de Sanjose S., Palacio V., Tafur L., Vazquez S., Espitia V., Vazquez F., et al. Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993, 2:531-535.
32. Leon S., Sanchez R., Patarroyo M.A., Camargo M., Mejia A., Urquiza M., et al. Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot, Colombia. Sex Transm Dis 2009, 36:290-296.
33. Rousseau M.C., Pereira J.S., Prado J.C., Villa L.L., Rohan T.E., Franco E.L. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001, 184:1508-1517.
34. Kenney J.W. Ethnic differences in risk factors associated with genital human papillomavirus infections. J Adv Nurs 1996, 23:1221-1227.
35. Soto-De Leon S.C., Camargo M., Sanchez R., Leon S., Urquiza M., Acosta J., et al. Prevalence of infection with high-risk human papillomavirus in women in Colombia. Clin Microbiol Infect 2009, 15:100-102.
36. Cervantes J., Lema C., Valentina Hurtado L., Andrade R., Hurtado Gomez L., Torrico L., et al. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women. Hum Immunol 2003, 64:890-895.
37. Javanbakht M., Gorbach P.M., Amani B., Walker S., Cranston R.D., Datta S.D., et al. Concurrency, sex partner risk, and high-risk human papillomavirus infection among African American, Asian, and Hispanic women. Sex Transm Dis 2010, 37:68-74.
38. Mejlhede N., Bonde J., Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 2009, 117:108-114.
39. Castellsague X., Bosch F.X., Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002, 89:191-199.
40. Rousseau M.C., Abrahamowicz M., Villa L.L., Costa M.C., Rohan T.E., Franco E.L. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003, 12:1029-1037.
41. Hindryckx P., Garcia A., Claeys P., Gonzalez C., Velasquez R., Bogers J., et al. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix. Sex Transm Infect 2006, 82:334-336.
42. Baldez da Silva M.F., Chagas B.S., Guimaraes V., Katz L.M., Felix P.M., Miranda P.M., et al. HPV31 and HPV33 incidence in cervical samples from women in Recife. Brazil. Genet Mol Res 2009, 8:1437-1443.
43. Ault K.A. Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecol Oncol 2007, 107(2 Suppl 1):S31-S33.